**Core Concept**
Platelet transfusion is indicated when thrombocytopenia leads to bleeding risk, especially in conditions with low platelet counts and active bleeding. However, in immunogenic thrombocytopenia, platelets are destroyed by the immune system, and transfused platelets may be rapidly consumed or inactivated, reducing effectiveness.

**Why the Correct Answer is Right**
In immunogenic thrombocytopenia (e.g., immune thrombocytopenic purpura), platelets are destroyed by antibodies, and transfused platelets are often rapidly cleared by the immune system. This leads to a short-lived response and increased risk of alloimmunization. The underlying mechanism is immune-mediated destruction, not a deficiency in platelet production or function. Therefore, transfusion is not effective and may even worsen outcomes due to immune reactions.

**Why Each Wrong Option is Incorrect**
Option A: In dilutional thrombocytopenia (e.g., massive transfusion), platelet count drops due to fluid overload. Platelet transfusion is indicated to correct the low count and prevent bleeding.
Option C: Aplastic anemia involves bone marrow failure and low platelet production. Platelet transfusion is used to prevent bleeding in acute phases.
Option D: In disseminated intravascular coagulation (DIC), thrombocytopenia is a hallmark due to consumption of platelets. Platelet transfusion is indicated to correct bleeding risk and stabilize coagulation.

**Clinical Pearl / High-Yield Fact**
Platelet transfusion is ineffective in immune-mediated thrombocytopenia and should be avoided in favor of corticosteroids or immunosuppressants. Always consider the cause of thrombocytopenia before transfusing platelets.

✓ Correct Answer: B. Immunogenic Thrombocytopenia